Oncolytics Biotech Inc. (ONCY) Revenue History
Annual and quarterly revenue from 1999 to present
ONCY Revenue Over Time (1999–2025)
ONCY Revenue Growth History
3 of 6 years with positive growth- FY1999 revenue growth
- N/A
- FY2000 revenue growth
- N/A
- FY2001 revenue growth
- -100.0%
- FY2002 revenue growth
- N/A
- FY2003 revenue growth
- +50.0%
- FY2004 revenue growth
- +123.3%
- FY2005 revenue growth
- +12.0%
- FY2006 revenue growth
- -100.0%
- FY2007 revenue growth
- N/A
- FY2008 revenue growth
- N/A
- FY2009 revenue growth
- N/A
- FY2010 revenue growth
- N/A
- FY2011 revenue growth
- N/A
- FY2012 revenue growth
- N/A
- FY2013 revenue growth
- -100.0%
- FY2014 revenue growth
- N/A
- FY2015 revenue growth
- N/A
- FY2016 revenue growth
- N/A
- FY2017 revenue growth
- N/A
- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $0 | — |
| Q4 2025 | $0 | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
ONCY Revenue Analysis (1999–2025)
Current Revenue & Growth
As of June 22, 2026, Oncolytics Biotech Inc. (ONCY) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue
Historical Growth Trajectory
ONCY's historical revenue data shows various trends over time. Oncolytics Biotech Inc.'s highest annual revenue of $4.9 million was recorded in 2012.
Peer Comparison
Compared to Healthcare sector peers — including CLDX (-89.2% YoY), NKTR (-36.2% YoY), and VVOS (+33.8% YoY). Compare ONCY vs CLDX →
ONCY Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ONCYCurrent | $0 | - | - | - | |
 CLDX | $2M | -89.2% | -27.4% | -19160.0% | |
 NKTR | $55M | -36.2% | -18.4% | -236.8% | |
 VVOS | $17M | +33.8% | +5.9% | -114.1% | |
 AMGN | $36.7B | +9.1% | +7.6% | 29.1% |
ONCY Historical Revenue Data (1999–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-39,414,434 | - |
| 2024 | $0 | - | $0 | - | $-34,982,000 | - |
| 2023 | $0 | - | $-298,587 | - | $-25,036,175 | - |
| 2022 | $0 | - | $-301,109 | - | $-20,681,282 | - |
| 2021 | $0 | - | $-360,575 | - | $-20,925,470 | - |
| 2020 | $0 | - | $-332,652 | - | $-18,980,827 | - |
| 2019 | $0 | - | $-485,574 | - | $-20,693,357 | - |
| 2018 | $0 | - | $-95,375 | - | $-16,662,679 | - |
| 2017 | $0 | - | $-90,768 | - | $-15,605,454 | - |
| 2016 | $0 | - | $-162,233 | - | $-15,294,507 | - |
| 2015 | $0 | - | $-180,411 | - | $-13,917,701 | - |
| 2014 | $0 | - | $0 | - | $-18,822,946 | - |
| 2013 | $0 | -100.0% | $0 | - | $-23,898,724 | - |
| 2012 | $4.9M | - | $0 | - | $-36,688,050 | -756.2% |
| 2011 | $0 | - | $-5,334,582 | - | $-28,721,267 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
27+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ONCY — Frequently Asked Questions
Quick answers to the most common questions about buying ONCY stock.
Is ONCY's revenue growth accelerating or slowing?
ONCY TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ONCY's revenue history from 1999 to 2026?
Oncolytics Biotech Inc. (ONCY) revenue history spans 1999 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is ONCY's long-term revenue growth rate (CAGR)?
Oncolytics Biotech Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for ONCY.
Why does ONCY's quarterly revenue fluctuate?
ONCY quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Oncolytics Biotech Inc.'s revenue data from 1999 to 2026 shows full historical quarterly detail on this page.
How is ONCY's revenue distributed by segment?
ONCY reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does ONCY's revenue compare to industry peers?
Oncolytics Biotech Inc. (ONCY) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.